These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34100166)

  • 1. Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study.
    Maehana T; Ichihara K; Takahashi S; Takahashi Y; Hashimoto K; Tanaka T; Masumori N
    Clin Exp Nephrol; 2021 Oct; 25(10):1151-1157. PubMed ID: 34100166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
    Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
    Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure.
    Okubo Y; Sairaku A; Morishima N; Ogi H; Matsumoto T; Kinoshita H; Kihara Y
    J Card Fail; 2018 Aug; 24(8):520-524. PubMed ID: 30026130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
    Katoh H; Nozue T; Kimura Y; Nakata S; Iwaki T; Kawano M; Kawashiri MA; Michishita I; Yamagishi M
    Heart Vessels; 2014 Mar; 29(2):191-7. PubMed ID: 23604313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study.
    Hikasa S; Shimabukuro S; Hideta K; Higasa S; Sawada A; Tokugawa T; Tanaka K; Yanai M; Kimura T
    Int J STD AIDS; 2018 Dec; 29(14):1424-1431. PubMed ID: 30114996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tubular and podocyte biomarkers in acute kidney injury.
    Matsui K; Kamijo-Ikemori A; Hara M; Sugaya T; Kodama T; Fujitani S; Taira Y; Yasuda T; Kimura K
    Clin Exp Nephrol; 2011 Apr; 15(2):220-5. PubMed ID: 21153750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention.
    Yoshihara F; Hosoda H; Doi T; Yoshida M; Kitamura K; Yamamoto H; Asaumi Y; Ishibashi-Ueda H; Kishida M; Arisato T; Matsuo M; Miyazato M; Yasuda S
    Clin Exp Nephrol; 2021 Dec; 25(12):1319-1328. PubMed ID: 34255252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine liver fatty acid binding protein and chronic kidney disease progression.
    Khatir DS; Bendtsen MD; Birn H; Nørregaard R; Ivarsen P; Jespersen B; Buus NH
    Scand J Clin Lab Invest; 2017 Nov; 77(7):549-554. PubMed ID: 28745927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.
    Huang YC; Chang YS; Chen CC; Tsai SF; Yu TM; Wu MJ; Chen CH
    Transplant Proc; 2018 May; 50(4):1083-1086. PubMed ID: 29731071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney injury biomarkers after cardiac angiography in children with congenital heart disease.
    Nishida M; Kubo S; Morishita Y; Nishikawa K; Ikeda K; Itoi T; Hosoi H
    Congenit Heart Dis; 2019 Nov; 14(6):1087-1093. PubMed ID: 31605509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate-intensity single exercise session does not induce renal damage.
    Hiraki K; Kamijo-Ikemori A; Yasuda T; Hotta C; Izawa KP; Watanabe S; Sugaya T; Kimura K
    J Clin Lab Anal; 2013 May; 27(3):177-80. PubMed ID: 23686775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term changes in renal function outcomes following radical cystectomy and urinary diversion.
    Nishikawa M; Miyake H; Yamashita M; Inoue TA; Fujisawa M
    Int J Clin Oncol; 2014 Dec; 19(6):1105-11. PubMed ID: 24445559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of urinary liver-type fatty acid-binding protein may indicate a lack of kidney protection during aortic arch surgery requiring hypothermic circulatory arrest.
    Mori Y; Sato N; Kobayashi Y; Ochiai R
    J Clin Anesth; 2014 Mar; 26(2):118-24. PubMed ID: 24582841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease.
    Fukuda Y; Miura S; Zhang B; Iwata A; Kawamura A; Nishikawa H; Shirai K; Saku K
    Intern Med; 2009; 48(19):1731-7. PubMed ID: 19797828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.
    Kubota Y; Higashiyama A; Marumo M; Konishi M; Yamashita Y; Okamura T; Miyamoto Y; Wakabayashi I
    BMC Nephrol; 2021 May; 22(1):189. PubMed ID: 34020611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
    Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
    Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy.
    McLeod DJ; Sebastião YV; Ching CB; Greenberg JH; Furth SL; Becknell B
    Pediatr Nephrol; 2020 Oct; 35(10):1907-1914. PubMed ID: 32444926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.